Multiple Myeloma Immunotherapy: Where Are We Now, with Alexander Lesokhin

Multiple Myeloma Immunotherapy: Where Are We Now, with Alexander Lesokhin

On September 13, 2016, Alexander M. Lesokhin, M.D., discussed immunotherapy treatment options for patients with multiple myeloma, and how close we are to making these treatments available to more patients. Dr. Lesokhin is an assistant attending physician on the Myeloma Service and Immunotherapeutics Core and a member of the Ludwig Collaborative Laboratory at Memorial Sloan Kettering Cancer Center.

This webinar is part of the Cancer Research Institute’s webinar series, “Cancer Immunotherapy and You,” which are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&A. This series is presented by Genentech and LabAnswer and its employees, with generous support from Abbvie, Celldex Therapeutics, NewLink Genetics, and Regeneron. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.